Goldman Sachs’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $333K | Buy |
112,084
+64,902
| +138% | +$193K | ﹤0.01% | 4470 |
|
2025
Q1 | $153K | Sell |
47,182
-6,548
| -12% | -$21.2K | ﹤0.01% | 4734 |
|
2024
Q4 | $212K | Buy |
53,730
+13,312
| +33% | +$52.6K | ﹤0.01% | 4645 |
|
2024
Q3 | $312K | Buy |
40,418
+27,252
| +207% | +$211K | ﹤0.01% | 4326 |
|
2024
Q2 | $67.7K | Sell |
13,166
-48,995
| -79% | -$252K | ﹤0.01% | 4537 |
|
2024
Q1 | $505K | Buy |
+62,161
| New | +$505K | ﹤0.01% | 3983 |
|
2022
Q3 | – | Sell |
-10,102
| Closed | -$57K | – | 5674 |
|
2022
Q2 | $57K | Sell |
10,102
-48,125
| -83% | -$272K | ﹤0.01% | 5255 |
|
2022
Q1 | $503K | Buy |
58,227
+16,739
| +40% | +$145K | ﹤0.01% | 4563 |
|
2021
Q4 | $462K | Sell |
41,488
-15,269
| -27% | -$170K | ﹤0.01% | 4573 |
|
2021
Q3 | $735K | Buy |
56,757
+29,183
| +106% | +$378K | ﹤0.01% | 4167 |
|
2021
Q2 | $456K | Buy |
27,574
+15,449
| +127% | +$255K | ﹤0.01% | 4483 |
|
2021
Q1 | $208K | Sell |
12,125
-452
| -4% | -$7.75K | ﹤0.01% | 4817 |
|
2020
Q4 | $197K | Sell |
12,577
-176
| -1% | -$2.76K | ﹤0.01% | 4281 |
|
2020
Q3 | $243K | Sell |
12,753
-19,992
| -61% | -$381K | ﹤0.01% | 3992 |
|
2020
Q2 | $449K | Sell |
32,745
-90,626
| -73% | -$1.24M | ﹤0.01% | 3648 |
|
2020
Q1 | $1.31M | Buy |
123,371
+104,153
| +542% | +$1.11M | ﹤0.01% | 2973 |
|
2019
Q4 | $359K | Buy |
19,218
+9,127
| +90% | +$170K | ﹤0.01% | 3799 |
|
2019
Q3 | $106K | Sell |
10,091
-1,859
| -16% | -$19.5K | ﹤0.01% | 4038 |
|
2019
Q2 | $91K | Sell |
11,950
-69,367
| -85% | -$528K | ﹤0.01% | 4007 |
|
2019
Q1 | $896K | Buy |
81,317
+71,281
| +710% | +$785K | ﹤0.01% | 3320 |
|
2018
Q4 | $51K | Buy |
+10,036
| New | +$51K | ﹤0.01% | 3971 |
|
2018
Q3 | – | Sell |
-11,513
| Closed | -$52K | – | 4252 |
|
2018
Q2 | $52K | Sell |
11,513
-9,758
| -46% | -$44.1K | ﹤0.01% | 4061 |
|
2018
Q1 | $114K | Sell |
21,271
-56,504
| -73% | -$303K | ﹤0.01% | 3992 |
|
2017
Q4 | $306K | Buy |
77,775
+31,467
| +68% | +$124K | ﹤0.01% | 3648 |
|
2017
Q3 | $202K | Sell |
46,308
-33,946
| -42% | -$148K | ﹤0.01% | 3881 |
|
2017
Q2 | $377K | Sell |
80,254
-18,545
| -19% | -$87.1K | ﹤0.01% | 3678 |
|
2017
Q1 | $1.63M | Buy |
98,799
+24,434
| +33% | +$403K | ﹤0.01% | 2856 |
|
2016
Q4 | $753K | Buy |
74,365
+59,979
| +417% | +$607K | ﹤0.01% | 3233 |
|
2016
Q3 | $194K | Sell |
14,386
-37,862
| -72% | -$511K | ﹤0.01% | 3947 |
|
2016
Q2 | $1.09M | Buy |
+52,248
| New | +$1.09M | ﹤0.01% | 2902 |
|
2016
Q1 | – | Sell |
-13,848
| Closed | -$151K | – | 4632 |
|
2015
Q4 | $151K | Sell |
13,848
-39,614
| -74% | -$432K | ﹤0.01% | 3847 |
|
2015
Q3 | $799K | Buy |
+53,462
| New | +$799K | ﹤0.01% | 3040 |
|